Abstract

Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2019 - Volume 23, Number 6

Page(s): 491

Download in electronic PDF format for $75

Abstract

A formulation for preparing Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2019 Pg. 491	Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
May/Jun 2020 Pg. 229	Prednisolone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 315	Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 234	Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 490	Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Mar/Apr 2019 Pg. 153	Tacrolimus 0.5 mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 333	Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Author(s): Allen Loyd V
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 53	Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 225	Dexamethasone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 319	Tacrolimus 0.06% Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 328	Tacrolimus 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 145	Naproxen 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 510	Imatinib 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 167-174	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA